ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Educational Symposium

Hyperkalemia: Understanding and Applying Innovative Approaches to the Management of CKD and ESKD

November 05, 2022 | 12:45 PM - 01:45 PM

Location: Regency Ballroom S, Hyatt Regency Orlando

Session Description

Hyperkalemia is defined as a serum potassium concentration greater than 5.0–5.5 mEq/L in adults. In acute or chronic kidney disease, this results from impaired urinary potassium excretion. Hyperkalemia is associated with significant morbidity and mortality in patients with CKD and ESKD. Clinicians typically recommend a multidisciplinary approach that involves modifying the diet; adjusting medication regimens that include RAAS blockers and ACE inhibitors, which can contribute to hyperkalemia; and starting potassium binders.

Understanding hyperkalemia and the latest clinical trial results in patients with CKD and ESKD is vital to improving outcomes. This symposium covers the benefits of pharmacological options for the management of hyperkalemia in CKD and for patients on dialysis.

Support is provided by an educational grant from AstraZeneca Pharmaceuticals.

Learning Objective(s)

  • Identify and summarize novel therapies for the treatment of hyperkalemia
  • Discuss the relationship between dietary potassium and serum potassium
  • Discuss the role of an interdisciplinary team in managing potassium in diet, medications, and behavior to reduce serum potassium
  • Describe the challenges of managing hyperkalemia in CKD and ESKD and how it affects patient outcomes

Learning Pathway(s)

  • Fluid‚ Electrolyte‚ and Acid-Base Disorders
  • CKD Non-Dialysis


  • Kim Zuber, PA, PA-C


  • Introduction: The Physiology of Hyperkalemia
    12:45 PM - 12:55 PM
    Kim Zuber, PA, PA-C
  • The Impact of Hyperkalemia in the Treatment of CKD
    12:55 PM - 01:15 PM
    Mitchell H. Rosner, MD, FASN
  • Pharmacological and Nonpharmacological Approaches to the Management of Hyperkalemia
    01:15 PM - 01:35 PM
    Biff F. Palmer, MD, FASN
  • Questions and Answers
    01:35 PM - 01:45 PM